Posted Oct. 11, 2013 at 10:40 a.m.

Premium Lock RTP firm Cirrus lands $700,000 grant to study inhaler performance

Published: 2013-10-11 10:40:35
Updated: 2013-10-11 10:40:35

Cirrus Pharmaceuticals Cirrus Pharmaceuticals

Cirrus, a contract drug and respiratory product developer, has landed a grant from the FDA to study the effectiveness of metered dose inhalers. The Morrisville-based firm is "growing" under new ownership....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders